author-photo

Courtney M. Tate

Eli Lilly and Company

2

Papers

11

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

A phase I study of Aurora kinase A inhibitor LY3295668 erbumine as a single agent and in combination in patients with relapsed/refractory neuroblastoma.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Immunomodulatory Activity of a Colony-Stimulating Factor-1 Receptor Inhibitor in Patients With Advanced Refractory Breast or Prostate Cancer: A Phase 1 Study.

2020 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (11)